Moreover, a recent study in diet-induced obese mice found that inhibition of MGAT activity in the liver leads to an improvement in glucose tolerance and in hepatic insulin signaling, suggesting that modulating MGAT activity could represent a possible target to alleviate obesity-associated hepatic metabolic dysfunction [50]. This evidence concerns the gene INS and Obesity.